What is the maximum daily dose, dosing interval, and maximum number of tablets per day for hydrocodone/acetaminophen 5 mg/325 mg in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dosing for Hydrocodone 5-325

For hydrocodone 5 mg/acetaminophen 325 mg, the maximum safe dosing is 1-2 tablets every 4-6 hours as needed, not to exceed 8 tablets per day (total daily dose: 40 mg hydrocodone/2600 mg acetaminophen), though this should be limited to 6 tablets per day (30 mg hydrocodone/1950 mg acetaminophen) to stay well below the 4-gram acetaminophen daily limit. 1

Specific Dosing Parameters

Frequency: Every 4-6 hours as needed

Maximum tablets per day: 8 tablets (per FDA labeling), but practically limit to 6 tablets to avoid acetaminophen toxicity

Maximum daily hydrocodone: 40 mg (8 tablets) per label, though 30 mg (6 tablets) is safer

Maximum daily acetaminophen: Must not exceed 4000 mg (4 grams) total from all sources

Critical Acetaminophen Consideration

The limiting factor here is actually the acetaminophen component, not the hydrocodone. While the FDA label states up to 8 tablets daily for the 7.5/750 mg formulation 1, with the 5/325 mg formulation:

  • 8 tablets = 2600 mg acetaminophen (acceptable but approaching limits)
  • 6 tablets = 1950 mg acetaminophen (safer margin)

Patients frequently exceed acetaminophen limits when using multiple formulations concurrently 2, so you must counsel patients to avoid other acetaminophen-containing products.

Morphine Milligram Equivalent (MME) Context

From a safety perspective, the CDC guidelines provide important context 3:

  • Starting dose for opioid-naïve patients: 20-30 MME/day
  • 6 tablets of hydrocodone 5 mg = 30 MME/day (hydrocodone conversion factor = 1.0)
  • 8 tablets = 40 MME/day

The CDC recommends pausing and carefully reassessing before exceeding 50 MME/day 3, as overdose risk increases progressively with dosage while benefits plateau. This means even the maximum labeled dose of 8 tablets (40 MME) approaches the threshold where careful risk-benefit reassessment becomes critical.

Practical Dosing Algorithm

For opioid-naïve patients:

  • Start: 1 tablet every 4-6 hours as needed
  • Maximum: 6 tablets/day (safer acetaminophen limit)
  • Absolute maximum per label: 8 tablets/day

For patients with hepatic insufficiency or concurrent acetaminophen use:

  • Further reduce maximum to 4-5 tablets/day
  • Consider lower-dose formulations (hydrocodone 2.5 mg/acetaminophen 325 mg exists) 3

For elderly patients (≥65 years):

  • Use additional caution due to smaller therapeutic window 3
  • Start with lower doses and extend dosing intervals

Common Pitfalls to Avoid

  • Concomitant acetaminophen products: Patients often don't realize other OTC medications contain acetaminophen, leading to inadvertent overdose 2
  • Rapid dose escalation: Increases overdose risk without proportional pain relief benefit 3
  • Ignoring the 4-gram acetaminophen limit: This is a hard stop regardless of pain control
  • Automatic refills without reassessment: CDC guidelines emphasize careful reevaluation before any dose increases 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.